FSD Pharma (TSE:HUGE) has released an update.
FSD Pharma Inc., a biopharmaceutical company, has announced a major stock consolidation and a rebranding as Quantum BioPharma Ltd. The consolidation will see shares reduced on a 65-to-1 basis, aiming to comply with Nasdaq’s minimum bid price requirement. Commencing on August 15, 2024, the new QNTM shares will trade on both the CSE and Nasdaq.
For further insights into TSE:HUGE stock, check out TipRanks’ Stock Analysis page.
